David Hyman active positions
| Companies | Position | Start | End |
|---|---|---|---|
| LOXO ONCOLOGY INC | Chief Tech/Sci/R&D Officer | 31/12/2019 | - |
| ELI LILLY AND COMPANY | Chief Tech/Sci/R&D Officer | 15/10/2023 | - |
Career history of David Hyman
Statistics
International
| United States | 3 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
Sectoral
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| Private companies | 1 |
|---|---|
Loxo Oncology, Inc.
 Loxo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Loxo Oncology, Inc. is a biopharmaceutical company, which engages in the development of small molecule therapeutics for the treatment of cancer. It focuses on genetic alterations, targeted therapies, and genetic testing. The company was founded by Joshua H. Bilenker in May 2013 and is headquartered in Stamford, CT. | Health Technology |
- Stock Market
- Insiders
- David Hyman
- Experience
